Iovance Biotherapeutics Inc (NAS:IOVA)
$ 7.99 0.04 (0.5%) Market Cap: 2.24 Bil Enterprise Value: 1.96 Bil PE Ratio: 0 PB Ratio: 3.30 GF Score: 40/100

Iovance Biotherapeutics Inc at Jefferies Healthcare Conference (Virtual) Transcript

Jun 01, 2021 / 07:30PM GMT
Release Date Price: $18.27 (-1.62%)
Michael Jonathan Yee
Jefferies LLC, Research Division - Equity Analyst

All right. Well, thank you, and good afternoon, and thank you for joining us on one of our afternoon sessions. I have the great pleasure of hosting Iovance here with me on the 2021 Global Jefferies Healthcare Conference. With us from Iovance is the Interim President and CEO, Fred Vogt, who also serves as General Counsel and has been with the company for many years now. So has a good perspective about things and certainly has some taste of everything going on and certainly capable of talking a lot about all the topics we have at hand.

Questions & Answers

Michael Jonathan Yee;Frederick G. Vogt
Jefferies LLC, Research Division - Equity Analyst;Iovance Biotherapeutics, Inc.

I guess I would just start off, Fred. First, maybe with a brief introduction to yourself briefly and to what extent you can talk a bit to Wall Street about the recent changes with management and where we're going with that. First is just an introduction. That would be a great start.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot